A. Mohamed

发表

Molecular and Phenotypic Characterization of Some Antimicrobial Resistance Genes in Escherichia coli Isolated from Human and Broiler Chickens

H. Shafik, M. Shehata, G. El-Sherbiny, 2016 .

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

M. Exline, Akram Khan, W. Self, 2022, BMJ.

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Samuel M. Brown, Manish M Patel, M. Exline, 2021, MMWR. Morbidity and mortality weekly report.

Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States

M. Exline, Akram Khan, W. Self, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

M. Exline, Akram Khan, W. Self, 2022, BMJ.

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

David W. McDonald, Meghan A. Wallace, Joel D. Levitt, 2021, MMWR. Morbidity and mortality weekly report.

Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States

A. Monto, D. Hager, N. Shapiro, 2022, medRxiv.

mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients

M. Exline, Akram Khan, W. Self, 2022, The Journal of infectious diseases.

Wellness and Coping of Physicians Who Worked in ICUs During the Pandemic: A Multicenter Cross-Sectional North American Survey*

H. Gershengorn, G. Martin, S. Bagshaw, 2022, Critical Care Medicine.

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021

Manish M Patel, M. Exline, Akram Khan, 2022, MMWR. Morbidity and mortality weekly report.

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Dynamics of anti-S IgG antibodies titers after the second dose of COVID 19 mRNA and non-mRNA vaccines in the manual and craft worker population of Qatar

M. Al-Thani, H. Al-Romaihi, S. Zughaier, 2022, medRxiv.

Evolution of New Variant Strains of Infectious Bronchitis Virus Isolated from Broiler Chickens

A. Mohamed, A. Ibrahim, 2015 .

Characteristics of Carbapenem-Resistant Gram-Negative Bacilli in Patients with Ventilator-Associated Pneumonia

A. Mohamed, E. Daef, Maggie A. Ibrahim, 2021, Antibiotics.

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States

Samuel M. Brown, Manish M Patel, H. Gershengorn, 2021, medRxiv.

First Isolation and identification of EHV-4 during abortion outbreak among Arabian horses in Egypt reflects an alteration in pathogenic potentiality of EHV-4

Shalaby, S. Salem, A. El-Sanousi, 2017 .

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

M. Exline, Akram Khan, W. Self, 2021, JAMA.

Hepatitis E virus infection in work horses in Egypt.

M. Saad, D. Fryauff, K. Earhart, 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States

Samuel M. Brown, Manish M Patel, H. Gershengorn, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

Manish M Patel, H. Gershengorn, M. Exline, 2021, Clinical Infectious Diseases.

Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.

M. Exline, Akram Khan, W. Self, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.

M. Exline, Akram Khan, W. Self, 2023, MMWR. Morbidity and mortality weekly report.

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022

M. Exline, Akram Khan, W. Self, 2022, Open forum infectious diseases.

Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States

M. Exline, Akram Khan, W. Self, 2022, Vaccine.

Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022

Akram Khan, W. Self, A. Ginde, 2023, Vaccine.

Response

W. Self, M. Semler, M. Shotwell, 2022, Chest.

Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months

David T. Huang, R. Hyzy, P. Morris, 2023, JAMA network open.

Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States

M. Exline, Akram Khan, W. Self, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

Michael L. Nelson, Brad T. Sherman, I. Douglas, 2023, The Lancet Respiratory Medicine.

Digital Commons

M. Exline, A. Ginde, A. Duggal, 2022 .

Digital Commons

M. Exline, A. Ginde, A. Duggal, 2022 .

Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023

M. Exline, Akram Khan, W. Self, 2023, MMWR. Morbidity and mortality weekly report.

SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis.

A. Lauring, J. Harcourt, Jennie H. Kwon, 2024, The Lancet. Microbe.

Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.

M. Exline, D. Yealy, A. Ginde, 2024, JAMA.